Abstract
In the last year (2020) the world has turned its attention to the new SARS-CoV2 virus, since the pandemic has brought to light Public Health problems that had already been raised over the past few years. Likewise, the frequent concern with bacterial resistance has been reported by many professionals who encounter patients with infections refractory to conventional pharmacological treatmen…